Balchem (BCPC)
(Delayed Data from NSDQ)
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Zacks News
Bears are Losing Control Over Blachem (BCPC), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Blachem (BCPC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Will Blachem (BCPC) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Blachem (BCPC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Momentum Stocks to Buy for August 24th
by Zacks Equity Research
BCPC, KEYS and AHT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 24, 2022.
Blachem (BCPC) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 9.52% and 6.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Blachem (BCPC) a New Strong Buy Stock
by Zacks Equity Research
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Reasons Growth Investors Will Love Blachem (BCPC)
by Zacks Equity Research
Blachem (BCPC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Blachem (BCPC) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 21.92% and 8.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ecolab (ECL) Surges 3.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Ecolab (ECL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Green Plains Renewable Energy (GPRE) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Green Plains (GPRE) delivered earnings and revenue surprises of -131.58% and 9.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
What Makes Blachem (BCPC) a New Buy Stock
by Zacks Equity Research
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks.com featured highlights include: Apple, Futu Holdings, Camtek and Balchem Corp
by Zacks Equity Research
Zacks.com featured highlights include: Apple, Futu Holdings, Camtek and Balchem Corp
4 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
Profitability analysis is one of the best ways to evaluate the prospects of a company.
Zacks.com featured highlights include: Balchem Corp, Civista Bancshares, H.B. Fuller and Nexstar Media Group
by Zacks Equity Research
Zacks.com featured highlights include: Balchem Corp, Civista Bancshares, H.B. Fuller and Nexstar Media Group
4 Profitable Stocks to Boost Returns Using Net Income Ratio
by Nitish Marwah
The net income ratio gives us the exact profitability level of a company. It reflects the percentage of net income to total sales revenues.
Blachem (BCPC) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Sell Stocks for March 26th
by Zacks Equity Research
BCPC, GELYY, QIWI, TJX, and RPAI have been added to the Zacks Rank #5 (Strong Sell) List on March 26, 2021
Blachem (BCPC) Q4 Earnings Top Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 23.88% and -0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Blachem (BCPC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 25th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Amyris (AMRS) Surges: Stock Moves 7.1% Higher
by Zacks Equity Research
Amyris (AMRS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Blachem (BCPC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Blachem (BCPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Blachem (BCPC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Blachem (BCPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Blachem (BCPC) Q3 Earnings Top Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 23.88% and -1.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Blachem (BCPC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.